Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The intent of this clinical study is to evaluate the safety of the injection composed of autologous bone marrow derived endothelial cells (BM-ECs) and platelet-rich plasma extract (PRPE) for the treatment of critical limb ischemia.
Epistemonikos ID: e75dba01493849c4c3aa8489c3eb2934ad7272b7
First added on: May 20, 2024